Tremors
Editat de Claudia Testa M., Dietrich Haubenbergeren Limba Engleză Hardback – 13 noi 2022
Preț: 595.94 lei
Preț vechi: 693.18 lei
-14% Nou
Puncte Express: 894
Preț estimativ în valută:
114.06€ • 120.32$ • 95.05£
114.06€ • 120.32$ • 95.05£
Carte disponibilă
Livrare economică 02-07 decembrie
Livrare express 27 noiembrie-03 decembrie pentru 111.09 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780197529652
ISBN-10: 0197529658
Pagini: 312
Dimensiuni: 256 x 181 x 22 mm
Greutate: 0.86 kg
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
ISBN-10: 0197529658
Pagini: 312
Dimensiuni: 256 x 181 x 22 mm
Greutate: 0.86 kg
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
Notă biografică
Claudia Testa, MD, PhD, Professor of Neurology and Chief of the Precision Medicine and Neurogenetics Division at University of North Carolina at Chapel Hill, completed Movement Disorders Fellowship at Emory University. After joining the Emory faculty, her work shifted from bench-based systems neuroscience to multi-center collaborative clinical trial and phenotype-genotype projects. She next served as the Joan Massey Chair in Clinical Parkinson Disease at Virginia Commonwealth University, and founded the VCU Huntington Disease Program. Dr. Testas interest in tremor began with a determined patient at Emory, and the commitment of tremor patients and families continues to inspire her.Dietrich Haubenberger, MHSc, MD is a voluntary Associate Clinical Professor in the Department of Neurosciences at the University of California, San Diego. He received his training as movement disorders neurologist at the Medical University of Vienna, Austria, after which he joined the Intramural Research Program at the National Institutes of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health, where he directed a Clinical Trials Unit. His research on tremor and other movement disorders spanned across clinical-genetic studies, neurophysiology, outcome measures, and clinical trials of tremor. In 2019, Dr. Haubenberger ventured into the pharmaceutical industry, leading clinical development programs in neurological indications at Neurocrine Biosciences, Inc..